Primary hepatocellular carcinoma and metabolic syndrome: An update

Table 3 Criteria used to define the metabolic syndrome

Diagnostic criterion	WHO (1999)	ATP (2005)	IDF (2006)
Abdominal obesity	BMI - Waist/hip ratio > 0.9 (men) or > 0.85 (women) or BMI ≥ 30 kg/m2	Central - Waist ≥ 102 cm (men) or ≥ 88 cm (women)	Central - Waist ≥ 102 cm (men) or ≥ 88 cm (women)
Hypertension	≥ 140/90 mmHg	≥ 130/85 mmHg or drug treatment for hypertension	≥ 130/85 mmHg or drug treatment for hypertension
Fasting glucose	IPG/HOMA	≥ 5.6 mol/L	≥ 6.1 mol/L
Hypertriglyceridemia	≥ 1.7 mmol/L (150 mg/dL) or drug treatment for elevated triglycerides	≥ 1.7 mmol/L (150 mg/dL) or drug treatment for elevated triglycerides	≥ 1.7 mmol/L (150 mg/dL) or drug treatment for elevated triglycerides
Low HDL cholesterol	Not used	< 1.0 mmol/L (40 mg/dL) (men); < 1.3 mmol/L (50 mg/dL) (women) or drug treatment for low HDL	< 1.0 mmol/L (40 mg/dL) (men); < 1.3 mmol/L (50 mg/dL) (women) or drug treatment for low HDL
Micro albuminuria	Used	Not used	Not used

ATP: Adult Treatment Panel; BMI: Body mass index; HDL: High-density lipoprotein; IDF: International Diabetes Federation; IPG/HOMA: Impaired plasma glucose/homeostatic model assessment; WHO: World Health Organization.